UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 171

Sortiert nach

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Journal of clinical oncology, 2014-08, Vol.32 (23), p.2423-2429

2014

Link zum Volltext

Verfügbarkeit prüfen

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

British journal of cancer, 2014-11, Vol.111 (10), p.1917-1923

2014

Link zum Volltext

Verfügbarkeit prüfen

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Annals of oncology, 2014-05, Vol.25 (5), p.1025-1032

2014

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of power Doppler ultrasound in patients with chronic tennis elbow

British journal of sports medicine, 2008-11, Vol.42 (11), p.872-876

2008

Link zum Volltext

Verfügbarkeit prüfen

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Journal of clinical oncology, 2017-10, Vol.35 (29), p.3330-3337

2017

Link zum Volltext

Verfügbarkeit prüfen

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation

Journal of clinical medicine, 2022-08, Vol.11 (16), p.4905

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2028-2034

2015

Link zum Volltext

Verfügbarkeit prüfen

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

European journal of cancer (1990), 2015-08, Vol.51 (12), p.1546-1554

2015

Link zum Volltext

Verfügbarkeit prüfen

40 nm, but not 750 or 1,500 nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin

Journal of investigative dermatology, 2006-06, Vol.126 (6), p.1316-1322

2006

Link zum Volltext

Verfügbarkeit prüfen

Profiling of Alopecia Areata Autoantigens Based on Protein Microarray Technology

Molecular & cellular proteomics, 2005-09, Vol.4 (9), p.1382-1390

2005

Link zum Volltext

Verfügbarkeit prüfen

Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy

TheScientificWorld, 2014, Vol.2014, p.452089-8

2014

Link zum Volltext

Verfügbarkeit prüfen

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial

BMC cancer, 2014-03, Vol.14 (1), p.204-204, Article 204

2014

Link zum Volltext

Verfügbarkeit prüfen

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

Annals of oncology, 2017-11, Vol.28 (11), p.2900-2900

2017

Link zum Volltext

Verfügbarkeit prüfen

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study

Journal of surgical oncology, 2013-11, Vol.108 (6), p.398-402

2013

Link zum Volltext

Verfügbarkeit prüfen

Aktuelle Diagnostik und Therapie des fortgeschrittenen Pankreaskarzinoms

Deutsche medizinische Wochenschrift, 2005-09, Vol.130 (38), p.2146-2148

2005

Link zum Volltext

Verfügbarkeit prüfen

Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

Onkologie, 2012, Vol.35 (12), p.755-760

2012

Link zum Volltext

Verfügbarkeit prüfen

Autosomal dominant inheritance in a large family with focal facial dermal dysplasia (Brauer–Setleis syndrome)

American journal of medical genetics. Part A, 2009-04, Vol.149A (4), p.746-750

2009

Link zum Volltext

Verfügbarkeit prüfen

Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays

Diagnostic microbiology and infectious disease, 2008-11, Vol.62 (3), p.235-244

2008

Link zum Volltext

Verfügbarkeit prüfen

Induction of apoptosis using 2',2'difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

Annals of hematology, 2000-09, Vol.79 (9), p.485

2000

Link zum Volltext

Verfügbarkeit prüfen

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”

Annals of oncology, 2017-11, Vol.28 (11), p.2900-2900

2017

Link zum Volltext

Verfügbarkeit prüfen

Induction of apoptosis using 2', 2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

Annals of hematology, 2000-09, Vol.79 (9), p.485-492

2000

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Evaluation of a New, Automated Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus-Specific Antibodies and Antigen

Journal of Clinical Microbiology, 2004-01, Vol.42 (1), p.21-29

2004

Link zum Volltext

Verfügbarkeit prüfen

Erythematosquamous dermatoses in adolescence

Hautarzt, 2016-04, Vol.67 (4), p.293-297

2016

Link zum Volltext

Verfügbarkeit prüfen

[alpha]-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

British journal of cancer, 2014-11, Vol.111 (10), p.1917

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Abbott ARCHITECT Toxo IgM assay

Diagnostic microbiology and infectious disease, 2009-07, Vol.64 (3), p.275-282

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Englisch
(151)
Deutsch
(19)
Japanisch
(10)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(63)
Humans
(52)
Male
(38)
Female
(36)
Animals
(28)
Biological And Medical Sciences
(20)
Adult
(19)
Oncology
(19)
Middle Aged
(18)
Aged
(17)
Medical Sciences
(16)
Physical Sciences
(13)
Hematology, Oncology And Palliative Medicine
(12)
Deoxycytidine - Analogs & Derivatives
(11)
Treatment Outcome
(11)
Aged, 80 And Over
(10)
Pancreatic Cancer
(10)
Medicine
(9)
Neurosciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Diagnostic accuracy of power Doppler ultrasound in patients with chronic tennis elbow

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

40 nm, but not 750 or 1,500 nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin

Profiling of Alopecia Areata Autoantigens Based on Protein Microarray Technology

Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial

SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study

Aktuelle Diagnostik und Therapie des fortgeschrittenen Pankreaskarzinoms

Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

Autosomal dominant inheritance in a large family with focal facial dermal dysplasia (Brauer–Setleis syndrome)

Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays

Induction of apoptosis using 2',2'difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”

Induction of apoptosis using 2', 2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells

Multicenter Evaluation of a New, Automated Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus-Specific Antibodies and Antigen

Erythematosquamous dermatoses in adolescence

[alpha]-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

Evaluation of the Abbott ARCHITECT Toxo IgM assay

Suchergebnisse filtern